2seventy bio (MEX:TSVT) Current Accrued Expense: MXN298.3 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TSVT 2seventy bio Inc MEX:TSVT
9 GF Score
Price MXN170.00
View Full Analysis

What is 2seventy bio Current Accrued Expense?

2seventy bio MEX:TSVT 9 Current Accrued Expense is MXN298.3 Mil as of Mar. 2025. GuruFocus rates MEX:TSVT with a GF Score™ of 9/100.

2seventy bio's Current Accrued Expense for the quarter that ended in Mar. 2025 was MXN298.3 Mil.

2seventy bio's quarterly Current Accrued Expense increased from Sep. 2024 (MXN235.9 Mil) to Dec. 2024 (MXN324.4 Mil) but then declined from Dec. 2024 (MXN324.4 Mil) to Mar. 2025 (MXN298.3 Mil).

2seventy bio's annual Current Accrued Expense declined from Dec. 2022 (MXN705.3 Mil) to Dec. 2023 (MXN312.6 Mil) but then increased from Dec. 2023 (MXN312.6 Mil) to Dec. 2024 (MXN324.4 Mil).

2seventy bio Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for 2seventy bio's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2seventy bio Current Accrued Expense Chart

2seventy bio Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Accrued Expense
Get a 7-Day Free Trial 626.16 450.51 705.33 312.60 324.43

2seventy bio Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 219.19 311.46 235.87 324.43 298.34
MEX:TSVT
9GF Score
2seventy bio Inc MEX:TSVT
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

2seventy bio Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of MXN298.3 Mil mean?
2seventy bio (MEX:TSVT) has a Current Accrued Expense of MXN298.3 Mil as of Mar. 2025. Current Accrued Expense records the total amount of accrued expenses. View historical data on 2seventy bio and its competitors.
Is 2seventy bio's Current Accrued Expense too high?
2seventy bio's current Current Accrued Expense is MXN298.3 Mil. Overall, 2seventy bio has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does 2seventy bio's Current Accrued Expense compare to ALMS and TERN?
2seventy bio's Current Accrued Expense of MXN298.3 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on 2seventy bio and its competitors. 2seventy bio's current Current Accrued Expense is MXN298.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 2seventy bio stock overvalued right now?
2seventy bio (MEX:TSVT) has a current Current Accrued Expense of MXN298.3 Mil. The current Current Accrued Expense is MXN298.3 Mil. 2seventy bio's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For 2seventy bio (MEX:TSVT), the current Current Accrued Expense is MXN298.3 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

2seventy bio Business Description

Address 60 Binney Street, Cambridge, MA, USA, 02142
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.
9GF Score

Get the complete analysis for MEX:TSVT

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price